$1.33 - AIM | AIM ImmunoTech Inc.

AIM ImmunoTech Inc. (AIM)

AIM ImmunoTech Inc.

XASE:AIM

1.33

-9.52%

Ask

$1.73 - 100.00

Bid

$1.22 - 200.00

Low

$1.38

High

$1.48

Open

$1.44

Prev Close

$1.47

52W High

52W Low

1.26

Volume

68326

Avg Vol (3m)

54497.1

Float

2737268.03

Chart

TendieTensor AI Analysis

Company

Asset Type: Common Stock

SIC Code: 2836

Sector: Health Technology

Industry: Pharmaceuticals: Major

Date Listed: 11/02/1995

Primary Exchange: XASE

AIM ImmunoTech Inc is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders, and to treat cancers for which there are currently inadequate or unmet therapies. Its flagship products are Ampligen (rintatolimod) and Alferon N Injection (Interferon alfa). Ampligen is a double-stranded RNA (dsRNA) molecule being developed for globally important cancers, viral diseases, and disorders of the immune system. Ampligen is approved for commercial sale in the Argentine Republic for the treatment of severe Chronic Fatigue Syndrome (CFS).

Phone: 352-448-7797

Address: 2117 Sw Highway 484

City: Ocala

State: FL

Postal Code: 32801

Website

TendieTensor AI Analyst Recommendation: —

Fundamentals

Total Employees:

P/E (TTM)

-0.070000

P/B (TTM)

-0.627700

EPS

-1.57

Round Lot

100

Composit FIGI

BBG000JL6Z80

Share Class FIGI

BBG001SB9J29

Share Class Shares Outstanding

2.71M

Weighted Shares Outstanding

2.76M

Technicals

RSI (14)

MACD Line

MACD Signal

SMA 20

SMA 50

EMA 50

Trend

Short Interest

—

Days to Cover

— —

Higher = harder to cover

Short Interest Δ

—

Prev: —

Short Volume Ratio (Today)

— —

5D avg: —

Squeeze Score (0–100)

—

Discussion